Mogroside IIe Ameliorates Cardiomyopathy by Suppressing Cardiomyocyte Apoptosis in a Type 2 Diabetic Model
Mogroside IIe is primarily present in the unripe fruit of Siraitia grosvenorii (Swingle) C. Jeffrey, and it is the predominant saponin component. The purpose of this study was to investigate the effects of mogroside IIe (MGE IIe) on myocardial cell apoptosis in diabetic cardiomyopathy (DCM) rats by...
Main Authors: | Xin Cai, Lingmin He, Guoao Zhou, Shenghua Li, Xinghua Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.650193/full |
Similar Items
-
Modulation of Nrf2 by quercetin in doxorubicin-treated rats
by: Anish Sharma, et al.
Published: (2020-04-01) -
Clustered gamma-protocadherins regulate cortical interneuron programmed cell death
by: Walter R Mancia Leon, et al.
Published: (2020-07-01) -
Complete Assembly of Escherichia coli Sequence Type 131 Genomes Using Long Reads Demonstrates Antibiotic Resistance Gene Variation within Diverse Plasmid and Chromosomal Contexts
by: Arun Gonzales Decano, et al.
Published: (2019-05-01) -
Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
by: Zhen Yang, et al.
Published: (2020-05-01) -
Mogroside IIE Inhibits Digestive Enzymes via Suppression of Interleukin 9/Interleukin 9 Receptor Signalling in Acute Pancreatitis
by: Juan Xiao, et al.
Published: (2020-06-01)